Blue Jet Healthcare Limited Cash Flow Conversion Efficiency
Blue Jet Healthcare Limited cash flow conversion efficiency. Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) has a cash flow conversion efficiency ratio of 0.165x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.07 Billion ≈ $22.41 Million USD) by net assets (Rs12.56 Billion ≈ $135.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Blue Jet Healthcare Limited (2020–2026)
Cash flow conversion efficiency of Blue Jet Healthcare Limited from 2020 to 2026. This chart illustrates how Blue Jet Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BLUEJET live share price for real-time trading data and today's change.
Blue Jet Healthcare Limited Cash Flow Conversion Ratio Explained
Blue Jet Healthcare Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Blue Jet Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Blue Jet Healthcare Limited ranked by their cash flow conversion efficiency. Also see Blue Jet Healthcare Limited market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Indo Count Industries Limited
NSE:ICIL
|
0.156x |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
0.106x |
|
Beijing Sanyuan Foods Co Ltd
SHG:600429
|
0.037x |
|
TAG Colonia-Immobilien AG
HM:KBU
|
N/A |
|
Shenzhen Das Intellitech Co Ltd
SHE:002421
|
-0.038x |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
0.076x |
|
Hanmi Financial Corporation
NASDAQ:HAFC
|
-0.011x |
|
Healthcare Global Enterprises Limited
NSE:HCG
|
0.136x |
Annual Cash Flow Conversion Efficiency for Blue Jet Healthcare Limited (2020–2026)
The table below shows the annual cash flow conversion efficiency of Blue Jet Healthcare Limited from 2020 to 2026. Review free cash flow generation of Blue Jet Healthcare Limited to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs13.60 Billion ≈ $147.07 Million |
Rs3.38 Billion ≈ $36.56 Million |
0.249x | +515.48% |
| 2025-03-31 | Rs11.33 Billion ≈ $122.54 Million |
Rs457.65 Million ≈ $4.95 Million |
0.040x | -85.85% |
| 2024-03-31 | Rs8.45 Billion ≈ $91.41 Million |
Rs2.41 Billion ≈ $26.09 Million |
0.285x | +37.42% |
| 2023-03-31 | Rs6.81 Billion ≈ $73.70 Million |
Rs1.42 Billion ≈ $15.31 Million |
0.208x | -26.01% |
| 2022-03-31 | Rs5.22 Billion ≈ $56.40 Million |
Rs1.46 Billion ≈ $15.83 Million |
0.281x | -26.57% |
| 2021-03-31 | Rs3.40 Billion ≈ $36.75 Million |
Rs1.30 Billion ≈ $14.05 Million |
0.382x | -36.84% |
| 2020-03-31 | Rs2.03 Billion ≈ $21.93 Million |
Rs1.23 Billion ≈ $13.27 Million |
0.605x | -- |
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more